Year: 2019
Type: letter
Abstract: Brain stimulation technologies, both invasive and non-invasive, have been successful in acquiring FDA approval for several indications within neuropsychiatry to include depression, Parkinson’s disease, and others. Unfortunately, despite extensive testing, brain stimulation has failed to be part of the clinical toolbox for treatment of stroke or brain injury. Epidural stimulation showed promise in early stages of validation but failed in phase III studies with a major limitation of delayed timing of intervention [1].
Source: Brain stimulation
Authors: Ali Alawieh, L. Fernando Gonzalez, Wuwei Feng
Institutions: Emory University, Duke University, Duke Medical Center
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,750
OpenAlex ID: W2989816570